SGLT2 inhibitors for kidney and heart disease Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease.
Chronic kidney disease: A patient perspective on navigating a new diagnosis GP Dr Kate Annear speaks with Dan and Jody, who have a lived experience with chronic kidney disease. They discuss helpful resources, as well as advice for health professionals looking to make the patient journey easier.
In Practice: Upskilling and networking opportunities A bumper edition of In Practice features new tips on named referrals, information on upcoming webinars, and much more.
Study identifies four main comorbidities associated with COVID deaths Coronavirus patients with cancer, chronic kidney disease, diabetes or hypertension were found to be most at risk of death.
Early warning sign for heart disease detected: Study The new research could help GPs identify patients at risk of cardiovascular disease years before symptoms arise.
Dire consequences of racism on kidney disease outcomes Urgent action is needed to confront the ‘immense’ health disparities experienced by Aboriginal and Torres Strait Islander people.
Study reinforces GP management of patients with chronic kidney disease Researchers have found a positive association between continuity of care and better blood pressure control in patients with chronic kidney disease.
Government rollout of remote renal dialysis The Federal Government has commenced its $34.8 million investment into providing renal dialysis for Aboriginal and Torres Strait Islander people in remote areas.
Women with diabetes more likely to get cancer, international study shows A global review involving almost 20 million people has shown that having diabetes significantly raises the risk of developing cancer, and for women the risk is even higher.
Kidney disease on the rise among older Australians: AIHW report Chronic kidney disease is increasing in older people, with the proportion of Australians aged 65–74 with the disease three times higher than for those aged 55–64, a recent report from the Australian Institute of Health and Welfare has found.